0001569706-18-000001.txt : 20181106
0001569706-18-000001.hdr.sgml : 20181106
20181106172037
ACCESSION NUMBER: 0001569706-18-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181028
FILED AS OF DATE: 20181106
DATE AS OF CHANGE: 20181106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LANHAM RANDALL J
CENTRAL INDEX KEY: 0001278724
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12033
FILM NUMBER: 181163980
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP
CENTRAL INDEX KEY: 0001018735
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9900 CAVENDISH BLVD., SUITE 306
STREET 2: ST. LAURENT
CITY: QUEBEC CANADA
STATE: A8
ZIP: H4M 2V2
BUSINESS PHONE: 1-800-936-9669
MAIL ADDRESS:
STREET 1: 9900 CAVENDISH BLVD., SUITE 306
STREET 2: ST. LAURENT
CITY: QUEBEC CANADA
STATE: A8
ZIP: H4M 2V2
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-10-28
0
0001018735
NYMOX PHARMACEUTICAL CORP
NYMX
0001278724
LANHAM RANDALL J
1
1
0
0
General Counsel
Common
2018-10-28
4
P
0
2900
1.72
A
152900
D
Randall J. Lanham
2018-11-06